Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines. J Infec Dis, 177, 310-319. presented at the 02/1998. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9466516. (1998).
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics, 108, E24. presented at the 2001.. (2001).
Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination. Ped J Infec Dis, 19, 417-23. presented at the 2000.. (2000).
Dose-Related Safety and Immunogenicity of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults. J Infec Dis, 193, 1223-1228. presented at the 05/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16586358. (2006).
The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children. N Engl J Med, 338, 1405-12. presented at the 1998.. (1998).
Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine. J Pediatric, 136, 168-175. presented at the 02/2000. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10657821. (2000).
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine, 18, 1902-9. presented at the 2000.. (2000).
Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons. J Infect Dis, 206, 811-820. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22782949. (2012).
In Utero Antiepileptic Drug Exposures: Differential IQ Outcomes in Children of Women With Epilepsy. Neurology, 67, 407-412. presented at the 08/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16894099. (2006).
Mucosal immune response to trivalent live-attenuated transnasal influenza vaccine in children. Vaccine, 18, 82-8. presented at the 1999.. (1999).
Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure. Clin Vaccine Immunol, 16, 558-566. presented at the 04/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19225073. (2009).
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine. N Engl J Med, 354, 1343-1351. presented at the 03/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16571878. (2006).